Maynard Um
-
-
-
-
-
-
-
Goldman Sachs Starts MBX Biosciences Inc (MBX) at Sell
-
-
-
-
-
-
-
Citizens sees blockbuster potential in MBX Biosciences (MBX) post phase 2 data
-
-
-
-
-
-
-
Oppenheimer Reiterates Outperform Rating on MBX Biosciences Inc (MBX)
-
-
-
-
-
-
-
MBX (MBX) Reports Q1 Loss of $0.71
-
-
-
-
-
-
-
MBX Biosciences (MBX) Announces Positive Phase 1 Topline Results for MBX 1416
-
-
-
-
-
-
-
MBX Biosciences (MBX) Opens At $23, IPO Priced At $16
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

